Literature DB >> 35590056

Mild MDPL in a patient with a novel de novo missense variant in the Cys-B region of POLD1.

Maya Chopra1,2, Richard Caswell3, Giulia Barcia4, Sophie Rondeau4, Laurence Jonard4,5, Patrick Nitchké6, Daniel Amram7, Marc-Lionel Bellaiche8, Veronique Abadie9, Marine Parodi10, Francoise Denoyelle10, Andrew Hattersley3, Christine Bole11,12, Stanislas Lyonnet1,11,13, Sandrine Marlin14,15,16.   

Abstract

DNA polymerase δ is one of the three main enzymes responsible for DNA replication. POLD1 heterozygous missense variants in the exonuclease domain result in a cancer predisposition phenotype. In contrast, heterozygous variants in POLD1 polymerase domain have more recently been shown to be the underlying basis of the distinct autosomal dominant multisystem lipodystrophy disorder, MDPL (mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome OMIM # 615381), most commonly a recurrent in-frame deletion of serine at position 604, accounting for 18 of the 21 reported cases of this condition. One patient with an unusually severe phenotype has been reported, caused by a de novo c. 3209 T > A, (p.(Ile1070Asn)) variant in the highly conserved CysB motif in the C-terminal of the POLD1 protein. This region has recently been shown to bind an iron-sulphur cluster of the 4Fe-4S type. This report concerns a novel de novo missense variant in the CysB region, c.3219 G > C, (p.(Ser1073Arg)) in a male child with a milder phenotype. Using in silico analysis in the context of the recently published structure of human Polymerase δ holoenzyme, we compared these and other variants which lie in close proximity but result in differing degrees of severity and varying features. We hypothesise that the c.3219 G > C, (p.(Ser1073Arg)) substitution likely causes reduced binding of the iron-sulphur cluster without significant disruption of protein structure, while the previously reported c.3209 T > A (p.(Ile1070Asn)) variant likely has a more profound impact on structure and folding in the region. Our analysis supports a central role for the CysB region in regulating POLD1 activity in health and disease.
© 2022. The Author(s), under exclusive licence to European Society of Human Genetics.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35590056      PMCID: PMC9349287          DOI: 10.1038/s41431-022-01118-6

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   5.351


  20 in total

1.  Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort.

Authors:  Nevin Ajluni; Rasimcan Meral; Adam H Neidert; Graham F Brady; Eric Buras; Barbara McKenna; Frank DiPaola; Thomas L Chenevert; Jeffrey F Horowitz; Colleen Buggs-Saxton; Amit R Rupani; Peedikayil E Thomas; Marwan K Tayeh; Jeffrey W Innis; M Bishr Omary; Hari Conjeevaram; Elif A Oral
Journal:  Clin Endocrinol (Oxf)       Date:  2017-03-27       Impact factor: 3.478

2.  POLD1 Germline Mutations in Patients Initially Diagnosed with Werner Syndrome.

Authors:  Davor Lessel; Fuki M Hisama; Katalin Szakszon; Bidisha Saha; Alexander Barrios Sanjuanelo; Bonnie A Salbert; Pamela D Steele; Jennifer Baldwin; W Ted Brown; Charles Piussan; Henri Plauchu; Judit Szilvássy; Edit Horkay; Josef Högel; George M Martin; Alan J Herr; Junko Oshima; Christian Kubisch
Journal:  Hum Mutat       Date:  2015-08-06       Impact factor: 4.878

3.  POLD1 deficiency is involved in cognitive function impairment in AD patients and SAMP8 mice.

Authors:  Shichao Gao; Xiaomin Zhang; Qiao Song; Jing Liu; Xunming Ji; Peichang Wang
Journal:  Biomed Pharmacother       Date:  2019-04-09       Impact factor: 6.529

4.  Exome sequencing reveals a de novo POLD1 mutation causing phenotypic variability in mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (MDPL).

Authors:  Sahar Elouej; Ana Beleza-Meireles; Richard Caswell; Kevin Colclough; Sian Ellard; Jean Pierre Desvignes; Christophe Béroud; Nicolas Lévy; Shehla Mohammed; Annachiara De Sandre-Giovannoli
Journal:  Metabolism       Date:  2017-03-28       Impact factor: 8.694

5.  Identification of a novel mutation in the polymerase delta 1 (POLD1) gene in a lipodystrophic patient affected by mandibular hypoplasia, deafness, progeroid features (MDPL) syndrome.

Authors:  Caterina Pelosini; Silvia Martinelli; Giovanni Ceccarini; Silvia Magno; Ilaria Barone; Alessio Basolo; Paola Fierabracci; Paolo Vitti; Margherita Maffei; Ferruccio Santini
Journal:  Metabolism       Date:  2014-07-25       Impact factor: 8.694

6.  A novel syndrome of mandibular hypoplasia, deafness, and progeroid features associated with lipodystrophy, undescended testes, and male hypogonadism.

Authors:  Savitha Shastry; Vinaya Simha; Koumudi Godbole; Paolo Sbraccia; Serge Melancon; Chittaranjan S Yajnik; Giuseppe Novelli; Matthias Kroiss; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2010-07-14       Impact factor: 5.958

7.  Characterization of MDPL Fibroblasts Carrying the Recurrent p.Ser605del Mutation in POLD1 Gene.

Authors:  Chiara Fiorillo; Maria Rosaria D'Apice; Federica Trucco; Michela Murdocca; Paola Spitalieri; Stefania Assereto; Serena Baratto; Guido Morcaldi; Carlo Minetti; Federica Sangiuolo; Giuseppe Novelli
Journal:  DNA Cell Biol       Date:  2018-11-02       Impact factor: 3.311

8.  The first Japanese patient with mandibular hypoplasia, deafness, progeroid features and lipodystrophy diagnosed via POLD1 mutation detection.

Authors:  Asami Okada; Tomohiro Kohmoto; Takuya Naruto; Ichiro Yokota; Yumiko Kotani; Aki Shimada; Yoko Miyamoto; Rizu Takahashi; Aya Goji; Kiyoshi Masuda; Shoji Kagami; Issei Imoto
Journal:  Hum Genome Var       Date:  2017-08-03

9.  A framework for the interpretation of de novo mutation in human disease.

Authors:  Kaitlin E Samocha; Elise B Robinson; Stephan J Sanders; Christine Stevens; Aniko Sabo; Lauren M McGrath; Jack A Kosmicki; Karola Rehnström; Swapan Mallick; Andrew Kirby; Dennis P Wall; Daniel G MacArthur; Stacey B Gabriel; Mark DePristo; Shaun M Purcell; Aarno Palotie; Eric Boerwinkle; Joseph D Buxbaum; Edwin H Cook; Richard A Gibbs; Gerard D Schellenberg; James S Sutcliffe; Bernie Devlin; Kathryn Roeder; Benjamin M Neale; Mark J Daly
Journal:  Nat Genet       Date:  2014-08-03       Impact factor: 38.330

10.  Structure of the processive human Pol δ holoenzyme.

Authors:  Claudia Lancey; Muhammad Tehseen; Vlad-Stefan Raducanu; Fahad Rashid; Nekane Merino; Timothy J Ragan; Christos G Savva; Manal S Zaher; Afnan Shirbini; Francisco J Blanco; Samir M Hamdan; Alfredo De Biasio
Journal:  Nat Commun       Date:  2020-02-28       Impact factor: 14.919

View more
  1 in total

1.  Exome sequencing-one test to rule them all?

Authors:  Alisdair McNeill
Journal:  Eur J Hum Genet       Date:  2022-08       Impact factor: 5.351

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.